• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    9.26 Up 0.11(1.20%) Mar 27, 4:00PM EDT
    |After Hours : 9.26 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 15,369   14,783   10,862   9,143  
    Cost of Revenue682  703  198   -  
    Gross Profit 14,687   14,080   10,664   9,143  
    Operating Expenses
    Research Development4,751  3,702  3,514  7,263  
    Selling General and Administrative17,323  11,289  28,139  27,893  
    Non Recurring -   -   -   -  
    Others536  536  617  565  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 69,693   (1,447) (21,606) (26,578)
    Income from Continuing Operations
    Total Other Income/Expenses Net77,642  22  31  45  
    Earnings Before Interest And Taxes147,335  (1,425)(21,575)(26,533)
    Interest Expense -   -   -   -  
    Income Before Tax147,335  (1,425)(21,575)(26,533)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops147,335  (1,425)(21,575)(26,533)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 69,719   (1,425) (21,575) (26,533)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 69,719   (1,425) (21,575) (26,533)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.